As part of PATH’s work in vaccine and pharmaceutical delivery technologies, this poster highlights PATH’s four-phase approach to designing a dissolvable microarray patch (MAP) for vaginal delivery of rilpivirine. In addition, the poster discusses the ways by which the approach has helped to define design requirements for an effective and discreet method (i.e., applicator) for delivering the long-lasting rilpivirine MAP for HIV pre-exposure prophylaxis.
Corporate author(s): PATH
Publication date: May 2016
1,180 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- Emerging and epidemic diseases > Drug development > HIV and AIDS
- Health technologies > Vaccine delivery
- Reproductive health > Sexually transmitted infections
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA